Multiple myeloma, version 1.2013.
Journal Article
These NCCN Guidelines Insights highlight the important updates/changes specific to the management of relapsed or progressive disease in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include the addition of new regimens as options for salvage therapy and strategies to mitigate the adverse effects and risks associated with newer regimens for the treatment of multiple myeloma.
Full Text
Duke Authors
Cited Authors
- Anderson, KC; Alsina, M; Bensinger, W; Biermann, JS; Cohen, AD; Devine, S; Djulbegovic, B; Faber, EA; Gasparetto, C; Hernandez-Illizaliturri, F; Huff, CA; Kassim, A; Krishnan, AY; Liedtke, M; Meredith, R; Raje, N; Schriber, J; Singhal, S; Somlo, G; Stockerl-Goldstein, K; Treon, SP; Weber, D; Yahalom, J; Yunus, F; Shead, DA; Kumar, R
Published Date
- January 1, 2013
Published In
Volume / Issue
- 11 / 1
Start / End Page
- 11 - 17
PubMed ID
- 23307977
Pubmed Central ID
- 23307977
Electronic International Standard Serial Number (EISSN)
- 1540-1413
Digital Object Identifier (DOI)
- 10.6004/jnccn.2013.0004
Language
- eng
Conference Location
- United States